Abstract
Cefotaxime is a broad-spectrum cephalosporin which is metabolized or degraded to less active or inactive metabolites by serum esterases, elevated temperatures, or a pH outside of its stability range. Cefotaxime instability during in vitro microbiological susceptibility tests may lead to an underestimation of the antibacterial activity of the compound. Cefotaxime and desacetylcefotaxime solutions were studied under MIC and serum inhibitory titer testing conditions. Cefotaxime concentrations, as measured by high-performance liquid chromatography, decreased 20 to 30% over the incubation period in various systems tested; the greatest decline occurred in systems containing serum in the media. Changes in the results of microbiological susceptibility tests interpreted after 6 and 18 h of incubation were consistent with changes observed in the high-performance liquid chromatography analysis. This study demonstrates cefotaxime instability under conditions of in vitro microbiological testing.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aldridge K. E., Sanders C. V., Marier R. L. In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides. Diagn Microbiol Infect Dis. 1984 Jun;2(3 Suppl):47S–53S. [PubMed] [Google Scholar]
- Berenbaum M. C. A method for testing for synergy with any number of agents. J Infect Dis. 1978 Feb;137(2):122–130. doi: 10.1093/infdis/137.2.122. [DOI] [PubMed] [Google Scholar]
- Chamberlain J., Coombes J. D., Dell D., Fromson J. M., Ings R. J., Macdonald C. M., McEwen J. Metabolism of cefotaxime in animals and man. J Antimicrob Chemother. 1980 Sep;6 (Suppl A):69–78. doi: 10.1093/jac/6.suppl_a.69. [DOI] [PubMed] [Google Scholar]
- Chin N. X., Neu H. C. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism. Diagn Microbiol Infect Dis. 1984 Jun;2(3 Suppl):21S–31S. [PubMed] [Google Scholar]
- Coombes J. D. Metabolism of cefotaxime in animals and humans. Rev Infect Dis. 1982 Sep-Oct;4 (Suppl):S325–S332. doi: 10.1093/clinids/4.supplement_2.s325. [DOI] [PubMed] [Google Scholar]
- Das Gupta V. Stability of cefotaxime sodium as determined by high-performance liquid chromatography. J Pharm Sci. 1984 Apr;73(4):565–567. doi: 10.1002/jps.2600730434. [DOI] [PubMed] [Google Scholar]
- Fabre H., Eddine N. H., Berge G. Degradation kinetics in aqueous solution of cefotaxime sodium, a third-generation cephalosporin. J Pharm Sci. 1984 May;73(5):611–618. doi: 10.1002/jps.2600730508. [DOI] [PubMed] [Google Scholar]
- Jones R. N., Barry A. L., Packer R. R. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci. Diagn Microbiol Infect Dis. 1984 Jun;2(3 Suppl):37S–46S. [PubMed] [Google Scholar]
- Reller L. B., Stratton C. W. Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests. J Infect Dis. 1977 Aug;136(2):196–204. doi: 10.1093/infdis/136.2.196. [DOI] [PubMed] [Google Scholar]
- Stratton C. W., Reller L. B. Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent. J Infect Dis. 1977 Aug;136(2):187–195. doi: 10.1093/infdis/136.2.187. [DOI] [PubMed] [Google Scholar]
- Wick W. E. Influence of antibiotic stability on the results of in vitro testing procedures. J Bacteriol. 1964 May;87(5):1162–1170. doi: 10.1128/jb.87.5.1162-1170.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yost R. L., Derendorf H. Rapid chromatographic determination of cefotaxime and its metabolite in biological fluids. J Chromatogr. 1985 May 31;341(1):131–138. doi: 10.1016/s0378-4347(00)84017-7. [DOI] [PubMed] [Google Scholar]